French pharma company Sanofi will help manufacture the Moderna coronavirus vaccine beginning in September, joining other companies assisting with the production of one of the three vaccines now approved in the US.
Under the agreement announced Monday, Sanofi will handle final manufacturing steps, including filling, inspecting and labelling vaccine vials and packaging them. The deal involves up to 200 million doses of Moderna’s two-shot vaccine.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…